At CDMO Live Europe, Dr. Vijay Vittal Mathad, Chief Operating Officer of CRAMSN Research Park, outlined how a genuine end-to-end CDMO model reduces friction across the drug development lifecycle, from supply chain resilience to sustainability, drawing on 32 years of pharmaceutical development experience.

Read the full article here.